Utah 2023 Regular Session

Utah Senate Bill SB0184

Introduced
2/7/23  
Refer
2/8/23  
Report Pass
2/13/23  
Engrossed
2/16/23  
Refer
2/24/23  
Report Pass
3/1/23  

Caption

Prescription Cost Amendments

Impact

The legislation is set to take effect for health benefit plans that are entered into or renewed after January 1, 2024. By explicitly stating how cost-sharing amounts are calculated, SB0184 aims to improve transparency regarding the financial responsibilities of health plan enrollees. The bill could potentially influence how individuals choose their health plans, especially those with high deductibles. Through these amendments, it seeks to mitigate the financial burden on patients receiving care while also providing a clear understanding of their cost-sharing obligations.

Summary

SB0184, officially titled 'Prescription Cost Amendments', introduces provisions aimed at regulating cost-sharing requirements for health benefit plans within the state of Utah. The bill defines various terms related to healthcare services and mandates that insurers and pharmacy benefit managers calculate cost-sharing amounts that have been paid on behalf of enrollees. This is significant as it ensures that out-of-pocket expenses are accurately reflected for individuals receiving health care services, including prescription drugs.

Sentiment

The sentiment surrounding SB0184 appears to be generally supportive among lawmakers focused on healthcare reform and consumer protection. Advocates argue that this measure will help to eliminate confusion related to out-of-pocket costs and enhance the affordability of healthcare for Utah residents. However, there may be concerns from insurers about the additional administrative burdens imposed by the new calculation requirements, leading to debates about the balance between consumer protection and industry regulation.

Contention

There are notable discussions regarding the scope and limitations placed upon pharmacy benefit managers and insurers in calculating contributions to cost-sharing requirements. Some stakeholders may perceive these regulations as excessively restrictive, potentially complicating existing practices in the pharmaceutical distribution and health insurance industries. As the bill progresses, it will be crucial to monitor discussions around potential amendments or clarifications that may address concerns from varying factions involved in healthcare provision.

Companion Bills

No companion bills found.

Similar Bills

IA SF383

A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025 Applicability date: 07/01/2025

IA HF852

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(Formerly HSB 99.)

IA SSB1074

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(See SF 383.)

IA HSB99

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(See HF 852.)

CA AB2863

Health care coverage: prescriptions.

NJ S3842

"Patient and Provider Protection Act."

NJ A4953

"Patient and Provider Protection Act."

NM HB132

Mail-order & Community Pharmacy Access